Collaborations involving the A*STAR Genome Institute of Singapore and 10x Genomics are launching large-scale spatial transcriptomics studies analyzing up to 2,500 patient tissue samples across multiple cancer types. Utilizing 10x Genomics’ Xenium platform, coupled with advanced AI algorithms, these projects aim to map tumor microenvironments at unprecedented resolution. The resulting data is expected to accelerate the identification of novel biomarkers and therapeutic targets, driving precision oncology advancements. This initiative received $17.8 million in funding and pairs spatial biology with computational innovations to enhance drug target discovery pipelines.